PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.39%
Negative revenue growth while ENPH stands at 1.99%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-28.35%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-194.50%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-360.84%
Negative operating income growth while ENPH is at 26.34%. Joel Greenblatt would press for urgent turnaround measures.
-375.90%
Negative net income growth while ENPH stands at 24.63%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-380.00%
Negative EPS growth while ENPH is at 21.74%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18766.67%
Negative diluted EPS growth while ENPH is at 22.73%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.90%
Slight or no buybacks while ENPH is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-50.22%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-68.37%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-68.37%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-70.54%
Negative 10Y revenue/share CAGR while ENPH stands at 20.31%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-59.76%
Negative 5Y CAGR while ENPH stands at 174.77%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-65.22%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
96.53%
10Y OCF/share CAGR at 50-75% of ENPH's 176.50%. Martin Whitman might fear a structural deficiency in operational efficiency.
-145.05%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
82.95%
Positive 3Y OCF/share CAGR while ENPH is negative. John Neff might see a big short-term edge in operational efficiency.
-672.69%
Negative 10Y net income/share CAGR while ENPH is at 2178.31%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-343.37%
Negative 5Y net income/share CAGR while ENPH is 174.41%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
23.54%
Positive short-term CAGR while ENPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
-111.62%
Negative equity/share CAGR over 10 years while ENPH stands at 511.02%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-812.15%
Negative 5Y equity/share growth while ENPH is at 125.96%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-155.81%
Negative 3Y equity/share growth while ENPH is at 112.35%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36.46%
AR growth well above ENPH's 17.72%. Michael Burry fears inflated revenue or higher default risk in the near future.
-52.87%
Inventory is declining while ENPH stands at 20.13%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
10.37%
Asset growth above 1.5x ENPH's 2.34%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-19.39%
We have a declining book value while ENPH shows 9.32%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
11.00%
Debt growth far above ENPH's 2.21%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-19.49%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.